drugset / Trial / NCT01753362

Liraglutide In Overweight Patients With Type 1 Diabetes

NCT01753362

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine the effects of liraglutide (a drug used to treat type 2 diabetes) on glucose (sugar) control over the 26 week study period when used in addition to insulin.

Timeline

Start
2012-12
Primary completion
2017-12
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Liraglutide Peptide Subcutaneous